Jagtome Rx 39
Payments companies reported to CMS as associated with Jagtome Rx 39. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jagtome Rx 39, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jagtome Rx 39
These are the largest totals companies reported as associated with Jagtome Rx 39. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thaer Abdelfattah | Providence, RI | Gastroenterology (Internal Medicine) | $101.54 |
| Benjamin Hewitt | Dothan, AL | Gastroenterology (Internal Medicine) | $72.81 |
| Fazel Dinary | Centerville, OH | Gastroenterology (Internal Medicine) | $51.20 |
| Omar Sadiq | Parma, OH | Gastroenterology (Internal Medicine) | $51.20 |
| John Trillo | Brooklyn, NY | Gastroenterology (Internal Medicine) | $43.38 |
| Amy Hosmer | Pittsburgh, PA | Gastroenterology (Internal Medicine) | $43.38 |
| Sara Samad | Neptune, NJ | Gastroenterology (Internal Medicine) | $43.37 |
| Samiran Roy Chaudhury | Brooklyn, NY | Internal Medicine | $43.37 |
| Michael Bernstein | Brooklyn, NY | Gastroenterology (Internal Medicine) | $43.37 |
| Muhammad Abdullah | Brooklyn, NY | Gastroenterology (Internal Medicine) | $43.37 |
Prescribed Jagtome Rx 39?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.